Discover Nkarta's groundbreaking cell therapy advancements, robust financials, and investment potential. Click here to read ...
Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback